Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

IBCL - 290

Light Chain Amyloidosis in Waldenstrφm Macroglobulinemia/Lymphoplasmacytic Lymphoma: Treatment Strategies and Outcomes of 74 Cases

Nicol? Danesin

Poster Presenter: Nicol? Danesin

Thumbnail for Patterns of Treatment Utilization and Sequencing Across Lines of Therapy in Waldenstrφm Macroglobulinemia: Real-World Evidence From the United States

IBCL - 291

Patterns of Treatment Utilization and Sequencing Across Lines of Therapy in Waldenstrφm Macroglobulinemia: Real-World Evidence From the United States

Jorge J Castillo

Poster Presenter: Jorge J Castillo

Previous 1...20 21 22 23 24 25 26...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

AML - 292

Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

Thumbnail for CD10 Loss Defines a Biologically Distinct and Extranodal-Enriched Subset of Follicular Lymphoma: A Systematic Review and Meta-Analysis

IBCL - 293

CD10 Loss Defines a Biologically Distinct and Extranodal-Enriched Subset of Follicular Lymphoma: A Systematic Review and Meta-Analysis

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

$Thumbnail for Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States$

ALL - 294

Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States

Marleni Torres Nunez

Poster Presenter: Marleni Torres Nunez

Thumbnail for Relapse-Mortality Trade-off Between Autologous and Allogeneic Stem Cell Transplantation in Relapsed Follicular lymphoma and Marginal zone lymphoma: A Registry-Based Proportional Meta-Analysis

IBCL - 295

Relapse-Mortality Trade-off Between Autologous and Allogeneic Stem Cell Transplantation in Relapsed Follicular lymphoma and Marginal zone lymphoma: A Registry-Based Proportional Meta-Analysis

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

Thumbnail for ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML

AML - 296

ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML

Abdelrahman Masheh

Poster Presenter: Abdelrahman Masheh

$Thumbnail for Correlation Among IL-8, TNF-α, and Overall Survival in Imetelstat-Treated Patients With Myelofibrosis Relapsed or Refractory to a Janus Kinase Inhibitor (JAKi) in the IMbark Trial$

MPN - 298

Correlation Among IL-8, TNF-α, and Overall Survival in Imetelstat-Treated Patients With Myelofibrosis Relapsed or Refractory to a Janus Kinase Inhibitor (JAKi) in the IMbark Trial

John Mascarenhas

Poster Presenter: John Mascarenhas

Thumbnail for Cardiovascular Toxicity, Bleeding, and Second Primary Malignancy Risk With Covalent vs Noncovalent BTK Inhibitors in CLL: A Systematic Review and Meta-Analysis

CLL - 299

Cardiovascular Toxicity, Bleeding, and Second Primary Malignancy Risk With Covalent vs Noncovalent BTK Inhibitors in CLL: A Systematic Review and Meta-Analysis

Elias Tayar

Poster Presenter: Elias Tayar

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors